Stockscreener 앱 받기
3.78
0.53%
0.02
시간 외 거래:
3.94
0.16
+4.23%
전일 마감가:
$3.76
열려 있는:
$3.77
하루 거래량:
2.31M
Relative Volume:
1.02
시가총액:
$371.88M
수익:
$361.07M
순이익/손실:
$-71.54M
주가수익비율:
-4.7848
EPS:
-0.79
순현금흐름:
$-47.97M
1주 성능:
+24.75%
1개월 성능:
+10.20%
6개월 성능:
+42.64%
1년 성능:
+1,543%
1일 변동 폭
$3.71
$4.00
1주일 범위
$3.04
$4.00
52주 변동 폭
$0.1706
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
명칭
Oncology Institute Inc
전화
562-735-3226
주소
18000 STUDEBAKER RD, CERRITOS
TOI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
3.78 | 369.91M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
484.77 | 110.07B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
199.40 | 17.38B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
222.60 | 14.03B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.60 | 13.55B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
107.00 | 10.75B | 5.51B | 494.70M | 386.40M | 4.84 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 개시 | Needham | Buy |
| 2025-07-23 | 개시 | Noble Capital Markets | Outperform |
| 2025-07-16 | 개시 | B. Riley Securities | Buy |
| 2025-05-15 | 개시 | BTIG Research | Buy |
| 2024-02-26 | 재개 | Jefferies | Buy |
| 2022-09-14 | 개시 | Guggenheim | Buy |
| 2022-08-15 | 개시 | Jefferies | Buy |
모두보기
Oncology Institute Inc 주식(TOI)의 최신 뉴스
Wall Street analysts’ outlook for Oncology Institute Inc (TOI) - setenews.com
Can The Oncology Institute Inc. Equity Warrant stock deliver strong Q4 earnings2025 Short Interest & Growth Focused Entry Point Reports - Newser
How The Oncology Institute Inc. Equity Warrant stock compares to market leadersMarket Sentiment Report & Weekly Sector Rotation Insights - Newser
This trade activity should not be overlooked: Oncology Institute Inc (TOI) - setenews.com
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute - Yahoo Finance
Why The Oncology Institute Inc. Equity Warrant stock could benefit from AI revolutionPortfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Is The Oncology Institute Inc. Equity Warrant stock a safe investment in uncertain marketsQuarterly Performance Summary & High Accuracy Swing Entry Alerts - Newser
Oncology Institute Announces Board Member Resignation - TipRanks
Oncology Institute Announces Board Resignation - TradingView
Oncology Institute director Gabe Ling resigns - TipRanks
The Oncology Institute Announces Resignation of Board Member Gabe Ling - The Manila Times
The Oncology Institute announces resignation of board member Gabe Ling - marketscreener.com
What analysts say about The Oncology Institute Inc stockPrice Volatility Patterns & Build a Dividend-Powered Portfolio - earlytimes.in
Is The Oncology Institute Inc. stock supported by strong fundamentalsEarnings Overview Summary & Expert Verified Movement Alerts - moha.gov.vn
The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Will The Oncology Institute Inc. Equity Warrant stock reach Wall Street targetsWeekly Risk Report & Free Technical Pattern Based Buy Signals - BỘ NỘI VỤ
US Stocks Recap: Will The Oncology Institute Inc. Equity Warrant stock split again soonWeekly Market Report & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Needham & Company LLC Initiates Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - ADVFN
Oncology Institute Projects Strong 2025 Revenue Growth - MSN
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - ADVFN
Oncology Institute initiated with a Buy at Needham - MSN
FreeGulliver LLC Decreases Stock Holdings in The Oncology Institute, Inc. $TOI - MarketBeat
There is no doubt that Oncology Institute Inc (TOI) ticks all the boxes. - Setenews
Needham Initiates Coverage on Oncology Institute With Buy Rating, $5 Price Target - MarketScreener
Oncology Institute (TOI) Gains "Buy" Rating with $5 Price Target by Needham | TOI Stock News - GuruFocus
Needham Initiates Coverage of Oncology Institute (TOI) with Buy Recommendation - Nasdaq
[Form 4] Oncology Institute, Inc. Insider Trading Activity - Stock Titan
Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 29% Hiding - simplywall.st
A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish - The Motley Fool
Oncology Institute (NASDAQ:TOI) Director Mark Pacala Sells 50,000 Shares - MarketBeat
Director’s Major Stock Sale at Oncology Institute! - TipRanks
Oncology Institute Director Sells 50,000 Shares - TradingView
[SCHEDULE 13D/A] Oncology Institute, Inc. SEC Filing - Stock Titan
Will The Oncology Institute Inc. stock outperform international peersJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
What data driven models say about The Oncology Institute Inc.’s future - newser.com
Using RSI to spot recovery in The Oncology Institute Inc. Equity WarrantJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
How to track smart money flows in The Oncology Institute Inc.Dollar Strength & Low Risk Investment Opportunities - newser.com
Is The Oncology Institute Inc. stock positioned for long term growthAnalyst Upgrade & Proven Capital Preservation Tips - newser.com
Ranking The Oncology Institute Inc. among high performing stocks via toolsTrade Volume Report & Real-Time Buy Zone Alerts - newser.com
77,000 Shares in The Oncology Institute, Inc. $TOI Bought by Mount Lucas Management LP - MarketBeat
Oncology Institute Inc (TOI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.03%
자본화:
|
볼륨(24시간):